Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

Mesenchymal stem cells (MSCs) are pluripotent cells that differentiate into a variety of cells, including cardiomyocytes and endothelial cells. However, little information is available regarding the therapeutic potency of systemically delivered MSCs for myocardial infarction. Accordingly, we investigated whether intravenously transplanted MSCs induce angiogenesis and myogenesis and improve cardiac function in rats with acute myocardial infarction. MSCs were isolated from bone marrow aspirates of isogenic adult rats and expanded ex vivo. At 3 h after coronary ligation, 5 x 10(6) MSCs (MSC group, n=12) or vehicle (control group, n=12) was intravenously administered to Lewis rats. Transplanted MSCs were preferentially attracted to the infarcted, but not the noninfarcted, myocardium. The engrafted MSCs were positive for cardiac markers: desmin, cardiac troponin T, and connexin43. On the other hand, some of the transplanted MSCs were positive for von Willebrand factor and formed vascular structures. Capillary density was markedly increased after MSC transplantation. Cardiac infarct size was significantly smaller in the MSC than in the control group (24 +/- 2 vs. 33 +/- 2%, P <0.05). MSC transplantation decreased left ventricular end-diastolic pressure and increased left ventricular maximum dP/dt (both P <0.05 vs. control). These results suggest that intravenous administration of MSCs improves cardiac function after acute myocardial infarction through enhancement of angiogenesis and myogenesis in the ischemic myocardium.

[1]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[3]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[4]  I. Komuro,et al.  Beating is necessary for transdifferentiation of skeletal muscle‐derived cells into cardiomyocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  R. Béliveau,et al.  Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation , 2003, Stem cells.

[6]  Yi Li,et al.  Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats , 2003, Circulation research.

[7]  K. Lachapelle,et al.  Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo , 2003, Gene Therapy.

[8]  H. Schäfers,et al.  Cardiomyocytes of Noncardiac Origin in Myocardial Biopsies of Human Transplanted Hearts , 2002, Circulation.

[9]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[10]  Qi-Long Ying,et al.  Changing potency by spontaneous fusion , 2002, Nature.

[11]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[12]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[13]  B. Goldman,et al.  Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.

[14]  D. Shum-Tim,et al.  Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. , 2000, The Journal of thoracic and cardiovascular surgery.

[15]  T. Horio,et al.  Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[17]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[18]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[19]  AnttiSaraste,et al.  Apoptosis in Human Acute Myocardial Infarction , 1997 .

[20]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[21]  J C Stanley,et al.  Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Trippodo,et al.  Increased ANF secretion after volume expansion is preserved in rats with heart failure. , 1988, The American journal of physiology.

[23]  Jacques Galipeau,et al.  Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. , 2003, The Annals of thoracic surgery.

[24]  福原 慎也.  Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro , 2003 .

[25]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.